about
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.Examining the interrelatedness of patient and spousal stress in heart failure: conceptual model and pilot data.Is there a nonadherent subtype of hypertensive patient? A latent class analysis approachUtility of hemoglobin A1c in predicting diabetes risk.Screening for diabetes in an outpatient clinic population.Clinical examination for the detection of protective sensation in the feet of diabetic patients. International Cooperative Group for Clinical Examination Research.A comparison of three health status measures in primary care outpatientsPrognostic value of the clinical examination of the diabetic foot ulcer.Shared medical appointments for patients with diabetes mellitus: a systematic review.Factors associated with persistent poorly controlled diabetes mellitus: clues to improving management in patients with resistant poor control.Quality of care for patients diagnosed with diabetes at screening.Late diagnosis of HIV infection: the role of age and sex.Nurse-led behavioral management of diabetes and hypertension in community practices: a randomized trial.Potassium and risk of Type 2 diabetesSimultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients.A multidimensional integrative medicine intervention to improve cardiovascular riskPotassium Measures and Their Associations with Glucose and Diabetes Risk: The Multi-Ethnic Study of Atherosclerosis (MESA).Lessons learned when innovations go awry: a baseline description of a behavioral trial-the Enhancing Fitness in Older Overweight Veterans with Impaired Fasting Glucose studyDoes Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans.Enhanced fitness: a randomized controlled trial of the effects of home-based physical activity counseling on glycemic control in older adults with prediabetes mellitus.Examining the impact of genetic testing for type 2 diabetes on health behaviors: study protocol for a randomized controlled trial.Effects of changes in potassium with valsartan use on diabetes risk: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.Impact of baseline insulin regimen on glycemic response to a group medical clinic intervention.Telemedicine cardiovascular risk reduction in veterans.A new look at screening and diagnosing diabetes mellitus.Comparison of medicine resident diabetes care between Veterans Affairs and academic health care systems.Tailored Case Management for Diabetes and Hypertension (TEACH-DM) in a community population: study design and baseline sample characteristicsThe Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction.Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study.Patient perceptions of a comprehensive telemedicine intervention to address persistent poorly controlled diabetes.ACP Journal Club. Review: Accuracy of monofilament testing for diagnosing peripheral neuropathy of the feet varies.A problem-solving intervention for cardiovascular disease risk reduction in veterans: Protocol for a randomized controlled trial.Novel Risk Factors for Type 2 Diabetes in African-Americans.Factors Associated With Having a Physician, Nurse Practitioner, or Physician Assistant as Primary Care Provider for Veterans With Diabetes Mellitus.To condition or not condition? Analysing 'change' in longitudinal randomised controlled trials.Bridging Income Generation with Group Integrated Care for cardiovascular risk reduction: Rationale and design of the BIGPIC study.Serum potassium is a predictor of incident diabetes in African Americans with normal aldosterone: the Jackson Heart Study.Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.Capsule Commentary on Min et al., Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes: How to Escalate Therapy for Patients who Fail Sulfonylureas.Do diabetic veterans use the Internet? Self-reported usage, skills, and interest in using My HealtheVet Web portal.
P50
Q33648354-B4C897EF-7529-4A63-A354-8725598BB66AQ33956799-E305662A-FEA9-4FD4-A4E9-702E0E9B56D4Q34042014-3DF4B0DB-D76D-4B30-88F8-7B2CAB5B1C64Q34733790-BE15745F-4014-4E79-A347-E85DE774C08AQ34742745-1DAEFCB2-8E8E-4878-9F21-31187F23FBAEQ34750029-E97D8611-77E5-4A59-B600-41BB5301DCC7Q34751179-210D762B-B5DB-430A-9AA6-91C6E7DE3BC8Q34753567-8AB2F024-09F2-4955-8AA2-3F5B4FB95C3BQ34826243-2934B86B-2FE2-4F55-9764-18AF552EC4CCQ35050011-20CA43E3-0FF0-40B8-B1ED-AEF2ED1A8042Q35053560-524DD877-A650-4D89-B9AA-72CA5A8492B7Q35248093-A156E24B-0A78-4E7A-B9A5-36C4B28BC217Q35396578-4ED61078-0F18-4BEF-B19A-0FB70391A0BDQ35400567-DC883E02-9840-4B9B-9A81-63AE8DE9B037Q35696136-EA314F2E-3625-4862-A21E-02C5266B4F1DQ35901549-5BBA19B6-5F90-40A3-AF4A-3FA6D8A2DCCBQ36046496-30272C1F-BB9D-4EE0-BCD3-5E360195ED9EQ36137676-B80B4CF7-E8CE-4D90-AA28-DEA2F7B4CD30Q36199476-F39C72AF-6430-4AF7-8D16-DA7C82CA0953Q36250467-B3742392-B4EF-4BBB-9A99-5A1711A1DF0AQ36298770-62EDA026-0890-42C8-9BEB-4E066F3328C0Q36442027-A171C3AA-AE06-481A-BFFE-195BA3FF836AQ36942062-8C40E010-7B3A-4C67-AD76-58C42E467C04Q37155878-AD6FA00B-D702-41C8-A104-B69B278F6FF7Q37156116-580F9D92-CF79-4C8D-873F-12A1ADFEBF2CQ37261373-2021C663-E07C-414D-82C8-49D0C9A02D9DQ37309996-65EE0CBD-E2D5-4FAA-A796-7E97AA78FF72Q37547831-9CFEBA5E-94F2-4821-A33D-8375532147D7Q37549763-D75CD45D-76EE-4E39-9A1D-CDC40B97BD4BQ37691650-6DA12E28-16D9-49E2-AC86-CBC555451C99Q37755887-2054290C-DA9E-431A-9435-818400FA0B64Q38375794-16569BDB-98FC-4713-B15C-453F6E8ED219Q38605086-20A69403-E81A-4632-A19F-A5DB14361C08Q38724661-0334BB47-F6D4-4A20-A015-184A3CF75D30Q39048778-232CAB8F-8418-4D47-8DD6-FDF152CD0D7EQ40174262-8022F0FB-9FFD-4C02-B4CA-8E89097A51C6Q40425117-BADD2A8D-651C-48CB-A6F8-A01D0D2BD75EQ41700610-DDDDFE11-F46C-43CF-9DDF-043BFE94C79AQ41882205-7440FF02-A0F9-466B-A38B-787B2EBCADCDQ43006523-27925A12-060F-45F3-8073-AAB14B7B0518
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Edelman
@ast
David Edelman
@en
David Edelman
@es
David Edelman
@nl
David Edelman
@sl
type
label
David Edelman
@ast
David Edelman
@en
David Edelman
@es
David Edelman
@nl
David Edelman
@sl
prefLabel
David Edelman
@ast
David Edelman
@en
David Edelman
@es
David Edelman
@nl
David Edelman
@sl
P106
P21
P31
P496
0000-0001-7112-6151